Mechanism-based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Mechanism-based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight. / Rajabi, Nima; Auth, Marina; Troelsen, Kathrin Rentzius; Pannek, Martin; Bhatt, Dhaval; Fontenas, Martin; Hirschey, Matthew; Steegborn, Clemens; Madsen, Andreas Stahl; Olsen, Christian Adam.
In: Angewandte Chemie, Int. Ed., Vol. 56, No. 47, 20.11.2017, p. 14836-14841.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Mechanism-based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight
AU - Rajabi, Nima
AU - Auth, Marina
AU - Troelsen, Kathrin Rentzius
AU - Pannek, Martin
AU - Bhatt, Dhaval
AU - Fontenas, Martin
AU - Hirschey, Matthew
AU - Steegborn, Clemens
AU - Madsen, Andreas Stahl
AU - Olsen, Christian Adam
PY - 2017/11/20
Y1 - 2017/11/20
N2 - The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more "drug-like" properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for sirtuins. This is important information when applying inhibitors to probe mechanisms in biology.
AB - The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more "drug-like" properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for sirtuins. This is important information when applying inhibitors to probe mechanisms in biology.
U2 - 10.1002/anie.201709050
DO - 10.1002/anie.201709050
M3 - Journal article
C2 - 29044784
VL - 56
SP - 14836
EP - 14841
JO - Angewandte Chemie International Edition
JF - Angewandte Chemie International Edition
SN - 1433-7851
IS - 47
ER -
ID: 184635999